Case 1

  • 12y, toy poodle, male, 4.84kg
  • Dx - TCC, hematuria, melena, DIC
  • PT ์ง€์—ฐ, APTT ์ง€์—ฐ, TEG ๋น„์ •์ƒ โ‡’ Consumptive coagulopathy (์†Œ๋ชจ์„ฑ ์‘๊ณ ๋ณ‘์ฆ)
  • ์ง€์†์ ์ธ ์—ผ์ฆ์œผ๋กœ DIC ๋ฐœ์ƒ

์ˆ˜์•ก ์ฒ˜์น˜๋งŒ ํ•˜๋ฉด โ†’ dilution์ด ๊ฐ€์žฅ ๋ฌธ์ œ. ํ˜ˆ์•ก์ด ํฌ์„๋จ. ์ด ํ™˜์ž์—์„œ ํ•„์š”ํ•œ Resuscitation = ์ˆ˜ํ˜ˆ

์ˆ˜ํ˜ˆ์˜ ์›์น™ : 3R

  • Right Timing (์–ธ์ œ?)
  • Right Material (๋ฌด์—‡์„? ์–ผ๋งˆ๋‚˜?)
  • Right technique (์–ด๋–ป๊ฒŒ?)

1. Right Timing

  • No transfusion trigger : ์ˆ˜ํ˜ˆ์˜ ํƒ€์ด๋ฐ์„ ํŒ๋‹จํ•  ์ˆ˜ ์žˆ๋Š” ๋ช…ํ™•ํ•œ trigger๋Š” ์—†์Œ.
  • tissue hypoxia(shock)์ผ ๋•Œ ์กฐ์ง์œผ๋กœ ์‚ฐ์†Œ๋ฅผ ์šด๋ฐ˜ํ•ด์ฃผ๊ธฐ ์œ„ํ•ด ์ˆ˜ํ˜ˆ ํ•„์š”.
์ˆ˜ํ˜ˆ์˜ ํŒ๋‹จ ๊ธฐ์ค€
Clinical signs
Shock์™€ ๊ด€๋ จ๋œ ์ฆ์ƒ์ด ์žˆ์„ ๋•Œ ์ˆ˜ํ˜ˆํ•˜ (์ฃผ๊ด€์ , ๊ฒฝํ—˜์  ์˜์—ญ..)
: tachycardia, pallor, weakness/exercise intolerant, elevated lactate, tachypnea, +/- hypotensive
PCV
- Chronic โ†’ PCV < 15% ์‹œ (์žฌ์ƒ๋ถˆ๋Ÿ‰์„ฑ ๋นˆํ˜ˆ, ์ข…์–‘)
: ๋นˆํ˜ˆ์˜ ์ƒํ™ฉ์— ์ ์‘ํ•  ์ˆ˜ ์žˆ๋Š” ์ถฉ๋ถ„ํ•œ ์‹œ๊ฐ„์ด ์žˆ์—ˆ์Œ
- Acute โ†’ 25-45% (suspect > 25-30% loss)
: ๊ธ‰์„ฑ์€ ์ ์‘ํ•  ์‹œ๊ฐ„์ด ์—†์Œ. ํ˜ˆ์•ก๋Ÿ‰์˜ 30% loss ์ผ์–ด๋‚˜๋ฉด ์ˆ˜ํ˜ˆ.
Hemoglobin
- < 7g/dL : hypoperfusion
- < 5-6g/dL : high risk of death
์˜ํ•™์ ์œผ๋กœ๋Š” Hgb๊ฐ€ ํ›จ์”ฌ sensitiveํ•œ marker์ด์ง€๋งŒ,
PCV๊ฐ€ ํ›จ์”ฌ ๊ธฐ๊ณ„์˜ ์˜ํ–ฅ์„ ๋œ ๋ฐ›๊ณ  ์ผ๊ด€์ ์ธ ์ˆ˜์น˜์—ฌ์„œ PCV๋กœ ๊ธฐ์ค€ ์žก์Œ.

2. Right Material

1๏ธโƒฃ RBC Transfusion

  • Wholed blood
    • Fresh WB
    • Stored WB
  • Packed RBC (pRBC)
RBC
๐Ÿฉธ Fresh whole blood (FWB)
- ์ฑ„ํ˜ˆ ํ›„ 4-6์‹œ๊ฐ„ ์ด๋‚ด, ํ˜ˆ์†ŒํŒ์ด ์‚ด์•„์žˆ๋Š” ํ˜ˆ์•ก
- RBC, WBC, platelet, coagulation factor ๋ชจ๋‘ ์žˆ์Œ
- Indication
ใ€€- Acute hemorrhage (surgery, trauma, organ rupture)
ใ€€- Evans syndrome (IMHA+IMT)
๐Ÿฉธ Stored whold blood (WB)
- ์ฑ„ํ˜ˆ ํ›„ 6์‹œ๊ฐ„์ด ์ง€๋‚˜๋ฉด(=ํ˜ˆ์†ŒํŒ ํŒŒ๊ดด) ์ €์žฅํ•ด์„œ ์‚ฌ์šฉ
- Stored 1-6โ„ƒ for 28 days (๋ƒ‰์žฅ๊ณ ์— 1๋‹ฌ๊นŒ์ง€ ์ €์žฅ)
- RBC, WBC, coagulation factor / Platelet (ํ˜ˆ์†ŒํŒ์€ ๊นจ์กŒ์ง€๋งŒ ์‘๊ณ ์ธ์ž๋Š” ์‚ด์•„ ์žˆ์Œ)
- Indication
ใ€€- Acute hemorrhage
ใ€€- Anemia with coagulopathy
๐Ÿฉธ Packed RBCs (pRBC)
- Whole blood์—์„œ RBC ๋ถ„๋ฆฌ
- Stored 1-6โ„ƒ for 35 days (๋ณด๊ด€ ๊ธฐ๊ฐ„์ด ์ข€ ๋” ๊ธธ๋‹ค)
- RBC, WBC (+with minimal plasma) : ์˜ค์ง ์ ํ˜ˆ๊ตฌ ์ˆ˜ํ˜ˆ๋งŒ ๊ฐ€๋Šฅ, ์‘๊ณ ์ธ์ž/albumin ๋“ฑ์€ ์—†์Œ
- Indication
ใ€€- Anemia without coagulopathy
ใ€€- FFP(Fresh plasma)์™€ ์„ž์–ด ์ „ํ˜ˆ์ฒ˜๋Ÿผ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ์Œ
๐Ÿฉธ Leukoreduced pRBCs
- Leukoreduction : ๋ฐฑํ˜ˆ๊ตฌ๋ฅผ ๊ฑฐ๋ฅด๋Š” ํ•„ํ„ฐ โ†’ ๋ฐฑํ˜ˆ๊ตฌ+ํ˜ˆ์†ŒํŒ ์ œ๊ฑฐํ•˜๊ณ  ์ ํ˜ˆ๊ตฌ๋งŒ ๋‚จ์Œ
- Post-storage๋ณด๋‹ค pre-storage๊ฐ€ ์ข‹์Œ (์ €์žฅ ์ „์— ํ•„ํ„ฐ๋ง)
- Leukocyte๋Š” cytokine์„ ๋ถ„๋น„ํ•˜๊ณ  transfusion reaction(FNHTRs)์„ ์œ ๋ฐœ - ์‚ฌ์‹ค ์ˆ˜ํ˜ˆ์— ์žˆ์–ด์„œ๋Š” ์œ ์ตํ•  ๊ฒŒ ํ•˜๋‚˜๋„ ์—†์Œ.
- ์ด๋Ÿฐ ๋ฐ˜์‘์ด ๋ฌธ์ œ๊ฐ€ ๋  ์ˆ˜ ์žˆ๋Š” ํ™˜์ž์—์„œ๋Š” leukoreduction์„ ๊ฑฐ์นœ ํ˜ˆ์•ก์„ ์ˆ˜ํ˜ˆ (๊ณผ๋ฏผ ๋ฐ˜์‘, ๋ฉด์—ญ์— ๋ฌธ์ œ ์žˆ๋Š” ํ™˜์ž)
๐Ÿฉธ Stored WB
- 1-6โ„ƒ refrigerator์—์„œ 28-35์ผ๊ฐ„ ๋ณด๊ด€.
- 2์ผ์— 1๋ฒˆ (EOD) ๋’ค์ง‘์–ด์ฃผ์ง€ ์•Š์œผ๋ฉด ํ˜ˆ์ „ ์ƒ๊น€.

Storage lesion

  • ์ €์žฅ ๊ธฐ๊ฐ„ ์ค‘ glucose๊ฐ€ ์†Œ๋ชจ๋˜์–ด ATP๊ฐ€ ์ƒ์„ฑ๋˜๊ณ , ์„ธ๊ท ์ด ์‚ด๊ธฐ ์ข‹์€ ํ™˜๊ฒฝ์ด ๋จ.
  • ์ ํ˜ˆ๊ตฌ ๊ธฐ๋Šฅ ์ €ํ•˜ ๋ฐ ํ•ฉ๋ณ‘์ฆ ์œ ๋ฐœ.
  • First In, First Out์œผ๋กœ ์‚ฌ์šฉ!
  • ๋‹จ ํŠน์ˆ˜ ์ƒํ™ฉ์—์„œ๋Š” ์šฐ์„ ์œผ๋กœ ์‹ ์„ ํ•œ ํ˜ˆ์•ก ์‚ฌ์šฉ
  • IMHA๋Š” ์ž๊ฐ€๋ฉด์—ญ ์งˆํ™˜์ด๋ฏ€๋กœ ํ˜ˆ์ „ ๊ฐ€๋Šฅ์„ฑ

2๏ธโƒฃ Plasma Transfusion

  • ์‘๊ณ ์ธ์ž ๋ณด์ถฉ์— ๊ฐ€์žฅ ๊ฐ•๋ ฅํ•œ ํšจ๊ณผ!
Plasma ์ข…๋ฅ˜
FFP (Fresh Frozen Plasma)Fresh WB์—์„œ ๋ฐ”๋กœ ํ˜ˆ์žฅ์„ ๋ถ„๋ฆฌํ•ด์„œ ๋งŒ๋“  ๊ฒƒ
FP (Frozen Plasma)8์‹œ๊ฐ„ ์ดํ›„, 24์‹œ๊ฐ„ ์ด๋‚ด ๋ฐ”๋กœ ๋ถ„๋ฆฌํ•ด์„œ ๋งŒ๋“ฆ
์•ฝ๊ฐ„์˜ ์‘๊ณ ์ธ์ž๋“ค์ด ํŒŒ๊ดด๋˜์—ˆ์ง€๋งŒ ํฐ ๋ฌธ์ œ ์—†์Œ
Thawed plasma37๋„์—์„œ ๋…น์—ฌ์„œ, 5์ผ๊ฐ„ ๋ƒ‰์žฅ ๋ณด๊ด€ํ•˜๋ฉฐ ์‚ฌ์šฉ

3๏ธโƒฃ Platelet Transfusion

  • ํ˜ˆ์†ŒํŒ์€ ์ฑ„ํ˜ˆ 6-8์‹œ๊ฐ„ ๋‚ด์— ํŒŒ๊ดด๋จ.
  • ์ด๋Ÿฐ ์ œ์ œ๋“ค์—์„œ ๊ฐ€๋Šฅ
    • Fresh Whole blood
    • Plastelet Rich Plasma

โ—๊ทธ๋ž˜์„œ? ํ˜ˆ์•ก ์ œ์ œ ๊ฒฐ์ •

์•„๋ž˜ ์„ค๋ช…์€ ๊ฐ๊ด€์‹์—์„œ ์ค‘์š”ํ•œ ๋‚ด์šฉ์ด์—ˆ๊ณ ..

๊ฒฐ์ •ํ•  ๋•Œ๋Š”

  1. ์ ํ˜ˆ๊ตฌ ์ˆ˜ํ˜ˆ์ด ํ•„์š”ํ•œ๊ฐ€? โ†’ RBC ์ค‘ ํ•˜๋‚˜
  2. ํ˜ˆ์†ŒํŒ, ์‘๊ณ ์ธ์ž๋Š” ํ•„์š”ํ•œ๊ฐ€?
    • ํ•„์š”ํ•˜๋ฉด Fresh WB !!!
    • ํ•„์š”ํ•˜์ง€ ์•Š์œผ๋ฉด pRBC
    • ํ˜ˆ์†ŒํŒ์€ ํ•„์š”์—†์ง€๋งŒ ์‘๊ณ ์ธ์ž๋Š” ํ•„์š”ํ•˜๋ฉด Stored WB
  3. ์ ํ˜ˆ๊ตฌ ์ •์ƒ์ด๊ณ  Coagulopathy๊ฐ€ ์žˆ๋‹ค๋ฉด โ†’ Plasma (FFP)
์ข…๋ฅ˜
RBCโ‡’PCV๊ฐ€ ๋–จ์–ด์ง„ ํ™˜์ž
Fresh Whole BloodRBC + WBC + ์‘๊ณ ์ธ์ž + platelet
Stored Whole BloodRBC + WBC + ์‘๊ณ ์ธ์ž
Packed RBCRBC + WBC (+minimal plasma)
Leukoreduced pRBCRBC (WBC, plasma ์ œ๊ฑฐ)
Plasmaโ‡’PCV๊ฐ€ ์ •์ƒ์ธ ํ™˜์ž
Fresh Frozen PlasmaHemostatic protein, ๋‹จ๋ฐฑ์งˆ ๋“ฑ
Frozen plasma

IMHA / PCV 14%, PLT 183 K/mcl, PT/aPTT - reference range
[2] HBC / PCV 17%, PLT 18 K/mcl, PT/aPTT - delayed
[3] PRCA / PCV 11%, PLT 158 K/mcl, PT/apTT - reference rage / 2์ฐจ ์ˆ˜ํ˜ˆ (1์ฐจ ์ˆ˜ํ˜ˆ ์‹œ FNHTR ๋ฐœ์ƒ)
[4] Hepatic mass / PCV 33%, PLT 210 k/mcl, PT/aPTT - delayed, ์•ˆ์ •ํ™” ํ•„์š”

  1. PCV ๊ฐ์†Œ โ‡’ ์ ํ˜ˆ๊ตฌ ํ•„์š” / PLT ์ •์ƒ (์ •์ƒ 11-12๋งŒ ์ด์ƒ, ํ˜„์žฌ 18๋งŒ) / ์‘๊ณ ๊ณ„ ์ •์ƒ โ‡’ pRBC ์ˆ˜ํ˜ˆ
  2. PCV ๊ฐ์†Œ โ‡’ ์ ํ˜ˆ๊ตฌ ํ•„์š” / PLT ์™„์ „ ๋‚ฎ์Œ, ์‘๊ณ ๊ณ„ ์ง€์—ฐ โ‡’ ํ˜ˆ์†ŒํŒ, ์‘๊ณ ์ธ์ž๋„ ๋ชจ๋‘ ํ•„์š” โ‡’ Fresh Whole Blood
  3. PCV ๊ฐ์†Œ / ํ˜ˆ์†ŒํŒ, ์‘๊ณ ๊ณ„ ์ •์ƒ / ๋น„์šฉํ˜ˆ์„ฑ ๋ฐœ์—ด ์ˆ˜ํ˜ˆ๋ฐ˜์‘(FNHTR) โ‡’ Leukoreduced pRBC
  4. PCV ์ •์ƒ โ‡’ ์ ํ˜ˆ๊ตฌ ์ค„ ํ•„์š” ์—†์Œ, ์‘๊ณ ๊ณ„ ์ง€์—ฐ โ‡’ ํ˜ˆ์žฅ โ‡’ FFP

3. Blood typing์— ๋”ฐ๋ฅธ ์ˆ˜ํ˜ˆ ๊ฐ€๋Šฅ ์—ฌ๋ถ€

ํ˜ˆ์•กํ˜• ๊ฒ€์‚ฌ โ†’ Cross-matching โ†’ ์ˆ˜ํ˜ˆ๋Ÿ‰ ๊ณ„์‚ฐ โ†’ ์ˆ˜ํ˜ˆ โ†’ ๋ชจ๋‹ˆํ„ฐ๋ง ์ˆœ!

1) Canine

  • DEA : 1, 3, 4, 5, 6, 7, 8, Dal

  • DEA 1, 4, Dal ์ฃผ์˜! ํŠนํžˆ 1ํ˜•์ด ๊ฐ€์žฅ ๋ฌด์„œ์šด ๋ฐ˜์‘์„ ์ผ์œผํ‚ด.

    • AHTR (Acute Hemolytic Transfusion Reaction) ์œ ๋ฐœ ๊ฐ€๋Šฅ
  • ๊ฐ™์€ ์• ๋“ค๋ผ๋ฆฌ๋Š” ๋‹น์—ฐํžˆ ๊ฐ€๋Šฅํ•˜๊ณ 

  • ๊ฐœ๋Š” ์ž์—ฐ๋ฐœ์ƒํ•ญ์ฒด๊ฐ€ ์—†์–ด์„œ 1์ฐจ ์ˆ˜ํ˜ˆ์—์„œ๋Š” ๋ฌธ์ œ๋ฅผ ์ผ์œผํ‚ค์ง€ ์•Š์Œ.

  • 2์ฐจ ์ˆ˜ํ˜ˆ๋ถ€ํ„ฐ๋Š” ์ฃผ์˜!

๐Ÿถ Canine transfusion
donor โ†’ recipient
DEA 1- โ†’ DEA 1+ (1์ฐจ)๊ฐ€๋Šฅ
DEA 1+ โ†’ DEA 1- (1์ฐจ)๊ฐ€๋Šฅ
DEA 1+ โ†’ DEA 1- (2์ฐจ)๋ถˆ๊ฐ€๋Šฅ
Dal + โ†’ Dal -๋ถˆ๊ฐ€๋Šฅ
  • DEA 1-๋Š” 2๋ฒˆ์งธ๋ถ€ํ„ด ๋ฐ›์„ ์ˆ˜ ์—†๋‹ค!!
  • DEA1-๊ฐ€ 1+์˜ ํ•ญ์›์„ ๋งŒ๋‚˜๋ฉด ๋ฐ˜์‘์„ ์ผ์œผํ‚ด (1์ฐจ ์ˆ˜ํ˜ˆ์—์„œ ํ•ญ์ฒด ์ƒ๊ฒจ์„œ 2์ฐจ ์ˆ˜ํ˜ˆ๋ถ€ํ„ฐ ๋ฐ˜์‘)

2) Feline

  • AB system : Aํ˜•์ด 95%
  • Aํ˜• ๊ณ ์–‘์ด๋Š” Bํ˜•์— ๋Œ€ํ•œ ํ•ญ์ฒด๋ฅผ, Bํ˜• ๊ณ ์–‘์ด๋Š” Aํ˜•์— ๋Œ€ํ•œ ํ•ญ์ฒด๋ฅผ ๊ฐ€์ง.
  • ์ž์—ฐ๋ฐœ์ƒ ํ•ญ์ฒด๋กœ, ์ฒซ ๋ฒˆ์งธ ์ˆ˜ํ˜ˆ๋ถ€ํ„ฐ ํ•ญ์›-ํ•ญ์ฒด ๋ฐ˜์‘์ด ์ผ์–ด๋‚จ.
  • ํŠนํžˆ Bํ˜• ๊ณ ์–‘์ด์—์„œ ์šฉํ˜ˆ๋ฐ˜์‘์ด ๋งค์šฐ ๊ฐ•ํ•จ ! ๋ฐ”๋กœ AHTR ๊ฐ€๋Šฅ.
๐Ÿ˜บ Feline transfusion
Aํ˜• โ†’ Aํ˜•์ž๊ธฐ ๊ฑฐ ๋ฐ›๋Š” ๊ฑด ๋‹ค ๊ฐ€๋Šฅ
Aํ˜•, ABํ˜• โ†’ Bํ˜• (1์ฐจ)๋ถˆ๊ฐ€๋Šฅ
: ์•„๋ฌดํŠผ Bํ˜•์€ A ์ ˆ๋Œ€ ๋ชป ๋ฐ›์Œ
Aํ˜• โ†’ ABํ˜•์กฐ์‹ฌ์Šค๋Ÿฝ๊ฒŒ ๊ฐ€๋Šฅ
: pRBC ํ˜•ํƒœ๋กœ ํ•ญ์ฒด ๋‹ค ๋นผ๊ณ  ์ˆ˜ํ˜ˆ.
(๋ฐ˜์‘ ๊ทธ๋‚˜๋งˆ ๋œํ•œ ํŽธ)
Bํ˜• โ†’ ABํ˜•๋ถˆ๊ฐ€
: ์•„๋ฌดํŠผ Bํ˜•์€ ๋ถˆ๊ฐ€, ์กฐ๊ธˆ๋งŒ ๋“ค์–ด๊ฐ€๋„ ๋‚œ๋ฆฌ๋‚จ

๊ฐœ์˜ 1์ฐจ ์ˆ˜ํ˜ˆ์€ ๋Œ€๋ถ€๋ถ„ ์•ˆ์ „ํ•˜์ง€๋งŒ, ๊ณ ์–‘์ด๋Š” 1์ฐจ ์ˆ˜ํ˜ˆ๋ถ€ํ„ฐ ์œ„ํ—˜ โ†’ ํ•ญ์ƒ Cross match!

์ˆ˜ํ˜ˆ ์šฉ๋Ÿ‰ ๊ฒฐ์ •

  • ์ˆ˜ํ˜ˆ์„ ํ•œ ๋ฒˆ์— ๋„ˆ๋ฌด ๋งŽ์ด ํ•ด๋„ ๋ถ€์ž‘์šฉ์ด ์žˆ๋‹ค.
    • ํ˜ˆ์•ก์€ ๋งค์šฐ ๊ฐ•๋ ฅํ•œ colloid๋ผ์„œ, ์ฃผ์œ„ ๋ฌผ์„ ๋Œ์–ด์™€์„œ fluid overload๋ฅผ ์œ ๋ฐœํ•˜๊ธฐ ๋•Œ๋ฌธ โ‡’ hypervolemic, ํ๋ถ€์ข…, ๋‡Œ๋ถ€์ข…
    • ํ˜น์‹œ ๋ฉด์—ญ๋ฐ˜์‘ ๋ฐœ์ƒํ•˜๋ฉด ๋ถ€์ž‘์šฉ ๋” ์‹ฌ๊ฐ

Guideline

  • 1st target : ํ™˜์ž์˜ ํ˜„์žฌ PCV๋ณด๋‹ค 10% ์˜ฌ๋ฆด ๋งŒํผ
  • ์ดํ›„ ์žฌํ‰๊ฐ€ - ๋ถ€์ž‘์šฉ ์—†์œผ๋ฉด ์ ˆ๋ฐ˜์ธ 5% rise ๋” ์ฃผ๊ณ 
  • ์žฌํ‰๊ฐ€ํ•˜๊ณ , ํ•„์š”ํ•˜๋ฉด ๋” ํˆฌ์—ฌ

๊ฐ„์ด ๊ณ„์‚ฐ์‹(pRBC ๊ธฐ์ค€) : 1.5mL x ์›ํ•˜๋Š” PCV rise % x BW
์›๋ž˜ ์‹์€ ((๋ชฉํ‘œ PCV - ํ˜„์žฌ PCV) / donor PCV) x ํ™˜์ž์˜ blood volume x BW

  • donor PCV๋Š” ๋ณดํ†ต ๋ฌธ์ œ์—์„œ ์ œ๊ณต (์ œํ’ˆ์— ๋‚˜์™€์žˆ์Œ)
  • blood volume์€ ๊ฐœ์—์„œ 80-90, ๊ณ ์–‘์ด์—์„œ 60

4. ์ ์šฉ๋ฒ•

Rate

  • ์ฒ˜์Œ 20๋ถ„๊ฐ„์€ ๋งค์šฐ ๋А๋ฆฐ ์†๋„๋กœ ์ฃผ์ž…ํ•˜๋ฉฐ AHTR ๋ชจ๋‹ˆํ„ฐ๋ง (0.25-0.5ml/kg/hr)
  • ๊ทธ ๋’ค๋กœ 5-10ml/kg/hr ์†๋„
  • ๋งค์šฐ ์‘๊ธ‰ํ•œ ์ƒํ™ฉ์ผ ๋•Œ๋Š” colloid ๊ฐ™์€ ํ˜ˆ์•ก์„ bolus IV๋กœ ํˆฌ์—ฌ

๋ถ€์ž‘์šฉ Monitoring

  • Baseline TPR
  • BT, HR, RR, BP, MM, CRT, Mental, urine

Xenotransfusion

  • ๊ณ ์–‘์ด ํ˜ˆ์•ก ๊ตฌํ•˜๊ธฐ๊ฐ€ ๋„ˆ๋ฌด ์–ด๋ ค์›Œ ๊ฐœ์˜ ํ˜ˆ์•ก์„ ๊ณ ์–‘์ด์— ์ˆ˜ํ˜ˆํ•˜๊ธฐ๋„ ํ•œ๋‹ค.
  • ๊ฐœ ํ˜ˆ์•กํ˜• ํ•ญ์›์— ๋Œ€ํ•œ ํ•ญ์ฒด๊ฐ€ ๊ณ ์–‘์ด์—๋Š” ์—†๊ธฐ ๋•Œ๋ฌธ์— ์ดˆ๋ฐ˜ 3-4์ผ ์ •๋„๋Š” ๊ฐ€๋Šฅ.
  • ํ•ญ์ฒด๊ฐ€ ์ƒ๊ธฐ๊ธฐ ์‹œ์ž‘ํ•˜๋ฉด ๋ถˆ๊ฐ€. ํ•ญ์ฒด ๋งŒ๋“ค์–ด๋‚ด๋Š” ์†๋„๊ฐ€ 4-7์ผ์ž„.
  • 4์ผ ์ •๋„๋งŒ ์‹œ๊ฐ„ ๋ฒŒ ์ˆ˜ ์žˆ์œผ๋‹ˆ ๊ทธ ๋™์•ˆ ๋น ๋ฅด๊ฒŒ ํ˜ˆ์•ก์„ ๊ตฌํ•ด๋ณด์ž..

Autotransfusion

  • Body cavity ์•ˆ์— ๊ณ ์ธ ํ˜ˆ์•ก์„ ๋นผ์„œ ๋‹ค์‹œ ๋„ฃ์–ด์คŒ
  • ์ž๊ธฐ ํ˜ˆ์•ก์ด๋ผ ๋ถ€์ž‘์šฉ ์—†๋Š” ๊ฒƒ์ด ์ตœ๊ณ  ์žฅ์ !
  • ํ˜ˆ์ „ ์„ฑ๋ถ„์ด ์—†์–ด์ ธ์„œ ํ•ญ์‘๊ณ ์ œ๋„ ํ•„์š”ํ•˜์ง€ ์•Š๊ณ , ๊นจ๋—ํ•˜๊ณ  ์‹ ์„ ํ•จ.
  • ๊ทธ๋Ÿฌ๋‚˜ ๋ฉธ๊ท ์ด ๋งค์šฐ ์ค‘์š”! ex) sepsis, ์žฅ ์ฒœ๊ณต์œผ๋กœ ํ˜ˆ์•ก ์˜ค์—ผ๋œ ๊ฒฝ์šฐ์—๋Š” ๋ถˆ๊ฐ€

5. Complications

์˜ˆ์ƒํ•˜๋Š” ๋ถ€์ž‘์šฉ์€ ๋ญ๊ฐ€ ์žˆ๋ƒ ํ•  ์ˆ˜๋„ ์žˆ์œผ๋‹ˆ ๊ฐ„๋‹จํ•˜๊ฒŒ๋งŒ ์ ์–ด๋ณด์ž๋ฉด..

Immunologic reaction
AHTR
(Acute hemolytic transfusion reactions)
- Type 2 sensitivity (Ag-Ab)
- donor ์ ํ˜ˆ๊ตฌ ํ•ญ์› + recipient ํ•ญ์ฒด
- ํ˜ˆ๊ด€๋‚ด ์šฉํ˜ˆ ๋จผ์ €
ใ€€โ†’ ํƒ์‹๋˜์–ด ๋น„์žฅ์—์„œ ์šฉํ˜ˆ๋จ (ํ˜ˆ๊ด€์™ธ)
- ์—ผ์ฆ โ†’ ๋ฐœ์—ด, ์‡ผํฌ ์ฆ์ƒ๋“ค
DHTR
(Delayed hemolytic transfusion reactions)
- ์ดˆ๋ฐ˜์—๋Š” ํ•ญ์ฒด๊ฐ€ ๋ฏธ์•ฝํ–ˆ์œผ๋‚˜,
- ํ•ญ์›์— ๋Œ€ํ•œ ๋ฐ˜์‘์œผ๋กœ ํ•ญ์ฒด๊ฐ€ ์ƒ์„ฑ๋˜๋ฉด์„œ
- 3-5์ผ ๋’ค์— ๋‚˜ํƒ€๋‚จ
FNHTR
(Febrile nonhemolytic transfusion reactions)
- donor์˜ ๋ฐฑํ˜ˆ๊ตฌ ํ•ญ์›์— ๋ฐ˜์‘ํ•˜์—ฌ ๋ฉด์—ญ/์—ผ์ฆ ๋ฐ˜์‘
- ์ ํ˜ˆ๊ตฌ๊ฐ€ ๊นจ์ง€๋Š” ๊ฑด ์•„๋‹˜
- leukoreduction filter๋กœ ๊ฑธ๋Ÿฌ์„œ ์ฃผ์ž
TRALI
(Transfusion related acute lung injury)
- ์ˆ˜ํ˜ˆ ์ดํ›„ ํ์นจ์œค์ด ๋ฐœ์ƒ
- ๋ฐฑํ˜ˆ๊ตฌ๋กœ ์ธํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์œผ๋กœ ํํ˜ˆ๊ด€ ์†์ƒ โ†’ ํ๋ถ€์ข…
- ๋น„์‹ฌ์›์„ฑ ํ๋ถ€์ข…์ด๋ฏ€๋กœ ์ด๋‡จ์ œ ๊ธˆ์ง€!
Allergic/anaphylactic- Type 1 hypersensitivity
ใ€€: donor ํ˜ˆ์•ก์˜ IgG, IgE์— ์˜ํ•ด
ใ€€: ์ ํ˜ˆ๊ตฌ๋ณด๋‹ค ํ˜ˆ์žฅ, ํ˜ˆ์†ŒํŒ ์ˆ˜ํ˜ˆ์—์„œ ๋” ๋งŽ์ด ๋ฐœ์ƒ
ใ€€: mildํ•˜๊ฒŒ๋Š” ํ”ผ๋ถ€ ๋ณ€ํ™”, anaphylaxis๋ฉด ์ €ํ˜ˆ์••/๋นˆ๋งฅ/๊ตฌํ† ์„ค์‚ฌ
Non-immunologic transfusion reaction
TACO
(Transfusion-associated circulatory overload)
- ํ˜ˆ์•ก์„ ๋„ˆ๋ฌด ๋งŽ์ด or ๋„ˆ๋ฌด ๋นจ๋ฆฌ ์ค˜์„œ
- ํ˜ˆ์•ก์€ ๊ฐ•๋ ฅํ•œ colloid๋ผ์„œ ์ •์ˆ˜์••์„ ์ฆ๊ฐ€์‹œํ‚ด
TACO : ํ˜ˆ์••์ด ์˜ค๋ฅด๊ณ  ํ๋ถ€์ข… ๋ฐœ์ƒ (โ†’ ์ด๋‡จ์ œ)
TRALI : ํ˜ˆ์•• ์ƒ์Šน ์—†์Œ, ์ด๋‡จ์ œ ๊ธˆ์ง€

Transfusion reaction์˜ ์น˜๋ฃŒ

์ผ๋‹จ ์ˆ˜ํ˜ˆ์„ ๋ฉˆ์ถ”๊ณ  + ํ•„์š”ํ•˜๋ฉด resuscitation (fluid, oxygen. vasopressor)

  • ๊ฐ์—ผ ์‹œ โ†’ Antibiotics
  • ์•Œ๋Ÿฌ์ง€ โ†’ Antihistamine (diphenhydramine)
  • NSAIDs
  • ํ˜ˆ์ „ โ†’ Anticoagulants (rivaroxaban, dalteparin)
  • ์‡ผํฌ โ†’ Epinephrine
  • TACO โ†’ Furosemide
  • hypocalcemia โ†’ Calcium gluconate